Objective — to analyze current scientific data on the etiological and pathogenetic mechanisms underlying the development of functional dyspepsia in children, as well as the characteristics of its pharmacological and dietary management.
Abstract
Disorders of gut-brain interaction, formerly known as functional gastrointestinal disorders, are widespread in primary care. Functional dyspepsia is a complex of clinical symptoms resulting from a disruption in the gut-brain axis; it is characterized by disturbances in the motor, secretory, and protective functions of the stomach and duodenum and does not require additional testing to rule out organic pathology. According to Rome V, functional dyspepsia is divided into two types: epigastric pain syndrome and postprandial distress syndrome. The main diagnostic criteria for epigastric pain syndrome include pain and burning in the epigastric region, which may be related to food intake and occur at least once a week for 2 months. The main diagnostic criteria for postprandial distress syndrome include complaints of early satiety and postprandial epigastric fullness, which occur within 2 hours after eating, at least 3 times a week for 2 months.
Objective — to analyze current scientific data on the etiological and pathogenetic mechanisms underlying the development of functional dyspepsia in children, as well as the characteristics of its pharmacological and dietary management.
Functional dyspepsia is a complex, multifactorial gastrointestinal disorder that is highly prevalent in the pediatric population. An effective approach to diagnosis and treatment is of great importance in the management of patients with functional dyspepsia. Treatment of functional dyspepsia in children necessarily includes lifestyle modifications, personalized dietary counseling, and medication. Pharmacological treatment of functional dyspepsia in children is provided in accordance with the ROME V, ESPGHAN, and NASPGHAN guidelines and is somewhat limited compared to treatment options for adults. Refractory forms of functional dyspepsia require patient consultation by a multidisciplinary team.
Functional dyspepsia (FD) is a disorder of gut–brain interaction affecting approximately 7% of the global population under Rome IV criteria, characterised by postprandial fullness, early satiation, epigastric pain, and/or epigastric burning in the absence of identifiable organic disease. Meal ingestion is the dominant...
Luisa Bertin, C. Van de Bruaene, E. Formisano et al.· Nutrients· 0 citations
The article addresses an urgent challenge of gastroesophageal reflux disease functional dyspepsia overlap. Studies reported a high prevalence rate of this phenomenon (up to 41% of patients with gastroesophageal reflux disease), which is associated with decreased quality of life and refractoriness against conventional t...
D. N. Andreev, M. A. Ovsepian, E. Barkalova et al.· Meditsinskiy sovet = Medical...· 0 citations
This paper provides a comprehensive review of the current state of knowledge on irritable bowel syndrome (IBS), one of the most common gastrointestinal disorders, currently classified as a disorder of gut–brain interaction (DGBI). The review discusses the epidemiology, pathophysiology, clinical presentation, diagnostic...
Marlena Radzka, Izabela Radzka, Paweł Budzik et al.· International Journal of Inn...· 0 citations
Background: Functional Dyspepsia (FD) is a common disorder of gut–brain interaction characterized by persistent upper abdominal symptoms without organic pathology. Conventional therapies often provide incomplete relief. Ayurveda offers multimodal approaches that may benefit FD symptomatology.
Case Presentation: A 42-ye...
Sumit Raina, Diksha Raina, Punita Pandey· Journal of Ayurveda and Inte...· 0 citations
Irritable bowel syndrome, chronic constipation, and functional diarrhoea are disorders of gut-brain interaction, the symptoms of which include abnormal stool consistency or frequency accompanied by varying degrees of abdominal pain, discomfort, bloating, or distension. These conditions affect 20% of the global populati...
C. Black, Kee-Huat Chuah, Yasmin Nasser et al.· The Lancet· 0 citations
Implementing an algorithm based on the Rome V criteria and contemporary international clinical guidelines enhances treatment efficacy, reduces relapse rate, and improves quality of life for affected children.
I. N. Zakharova, R. A. Faizullina, I. V. Berezhnaya et al.· Pediatrics. Consilium Medicu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.